Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Blessing · SciRah

Researcher profile · Semantic Scholar

J. Blessing

Share profile

J. Blessing — researcher profile on SciRah

h-index: 72
Works: 336
Citations: 19K

Most-cited papers

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
D. Moore, J. Blessing, R. McQuellon, H. Thaler +7 more
2004Journal of Clinical Oncology574 citations Open access
Semantic Scholar
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
M. Hensley, J. Blessing, K. Degeest, O. Abulafia +2 more
2008Gynecologic Oncology279 citations Open access
Semantic Scholar
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.
M. Markman, J. Blessing, S. Rubin, J. Connor +2 more
2006Gynecologic Oncology221 citations
Semantic Scholar
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
M. Hensley, J. Blessing, R. Mannel, P. Rose
2008Gynecologic Oncology212 citations Open access
Semantic Scholar
Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study.
William P. McGuire, J. Blessing, M. Bookman, S. Lentz +1 more
2000Journal of Clinical Oncology203 citations
Semantic Scholar
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Peter G. Rose, J. Blessing, D. Gershenson, R. Mcgehee
1999Journal of Clinical Oncology203 citations
Semantic Scholar
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.
D. Miller, J. Blessing, C. Krasner, R. Mannel +4 more
2009Journal of Clinical Oncology176 citations Open access
Semantic Scholar
Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
S. Lincoln, J. Blessing, R. Lee, T. Rocereto
2003Gynecologic Oncology169 citations
Semantic Scholar
Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study.
F. Muggia, J. Blessing, J. Sorosky, G. Reid
2002Journal of Clinical Oncology167 citations
Semantic Scholar
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.
P. Rose, J. Blessing, H. Ball, J. Hoffman +3 more
2003Gynecologic Oncology159 citations
Semantic Scholar
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study.
K. Look, A. Sandler, J. Blessing, J. Lucci +1 more
2004Gynecologic Oncology152 citations
Semantic Scholar
Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
M. Bookman, J. Blessing, Parviz Hanjani, Thomas J. Herzog +1 more
2000Gynecologic Oncology125 citations
Semantic Scholar
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.
A. Secord, J. Blessing, D. Armstrong, W. Rodgers +4 more
2008Gynecologic Oncology117 citations Open access
Semantic Scholar
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
J. Bloss, J. Blessing, B. Behrens, R. Mannel +4 more
2002Journal of Clinical Oncology111 citations
Semantic Scholar
A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
L. Muderspach, J. Blessing, C. Levenback, J. L. Moore
2001Gynecologic Oncology111 citations
Semantic Scholar
Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study.
John P. Curtin, J. Blessing, K. Webster, Peter G. Rose +4 more
2001Journal of Clinical Oncology106 citations
Semantic Scholar
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.
D. Dizon, J. Blessing, D. S. McMeekin, S. Sharma +2 more
2009Journal of Clinical Oncology97 citations Open access
Semantic Scholar
A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.
D. Miller, J. Blessing, S. Lentz, S. Waggoner
2002Gynecologic Oncology95 citations
Semantic Scholar
A Phase II Evaluation of Belinostat and Carboplatin in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
D. Dizon, J. Blessing, R. Penson, R. Drake +4 more
2012Gynecologic Oncology94 citations Open access
Semantic Scholar
A PHASE II EVALUATION OF TRABECTEDIN IN THE TREATMENT OF ADVANCED, PERSISTENT, OR RECURRENT UTERINE LEIOMYOSARCOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY
B. Monk, J. Blessing, D. Street, C. Muller +2 more
2011Gynecologic Oncology91 citations Open access
Semantic Scholar
Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.
J. Curtin, J. Blessing, J. Soper, K. Degeest
2001Gynecologic Oncology91 citations
Semantic Scholar
Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study.
J. A. Hurteau, J. Blessing, S. Decesare, W. Creasman
2001Gynecologic Oncology90 citations
Semantic Scholar
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
R. Schilder, J. Blessing, Mark A. Morgan, Charles E. Mangan +1 more
2000Gynecologic Oncology86 citations
Semantic Scholar
Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.
D. Gallup, J. Blessing, W. Andersen, M. Morgan
2003Gynecologic Oncology81 citations
Semantic Scholar
Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.
J. Thigpen, J. Blessing, K. Degeest, K. Look +1 more
2004Gynecologic Oncology76 citations
Semantic Scholar
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
Agustin Garcia, J. Blessing, S. Nolte, R. Mannel
2008Gynecologic Oncology72 citations
Semantic Scholar
Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
G. Sutton, J. Blessing, P. Hanjani, P. Kramer
2005Gynecologic Oncology67 citations
Semantic Scholar
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
D. Alberts, J. Blessing, L. Landrum, D. Warshal +4 more
2012Gynecologic Oncology66 citations Open access
Semantic Scholar
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
M. Hoffman, J. Blessing, S. Lentz
2003Gynecologic Oncology66 citations
Semantic Scholar
Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
D. Miller, J. Blessing, D. Bodurka, A. Bonebrake +1 more
2008Gynecologic Oncology65 citations
Semantic Scholar
Phase II Clinical Trial of Docetaxel in Refractory Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Agustin Garcia, J. Blessing, L. Vaccarello, L. Roman
2007American Journal of Clinical Oncology63 citations
Semantic Scholar
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
F. Muggia, J. Blessing, M. Method, D. Miller +3 more
2004Gynecologic Oncology63 citations
Semantic Scholar
Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study.
K. de Geest, J. Blessing, Robert T. Morris, S. Yamada +5 more
2010Journal of Clinical Oncology60 citations Open access
Semantic Scholar
Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
R. Schilder, J. Blessing, D. Cohn
2005Gynecologic Oncology60 citations
Semantic Scholar
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.
David S. Miller, J. Blessing, L. Kilgore, R. Mannel +1 more
2000American Journal of Clinical Oncology60 citations
Semantic Scholar
Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.
C. Brewer, J. Blessing, R. Nagourney, M. Morgan +1 more
2006Gynecologic Oncology59 citations
Semantic Scholar
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
P. Fracasso, J. Blessing, K. Molpus, L. M. Adler +2 more
2006Gynecologic Oncology59 citations
Semantic Scholar
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
C. Aghajanian, J. Blessing, K. Darcy, G. Reid +6 more
2009Gynecologic Oncology58 citations
Semantic Scholar
Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
P. Rose, J. Blessing, R. Buller, R. Mannel +1 more
2003Gynecologic Oncology55 citations
Semantic Scholar
Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
P. Rose, J. Blessing, S. Lele, O. Abulafia
2006Gynecologic Oncology53 citations
Semantic Scholar
Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.
M. Morris, J. Blessing, B. Monk, R. Mcgehee +1 more
2004Journal of Clinical Oncology50 citations
Semantic Scholar
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
C. Brewer, J. Blessing, R. Nagourney, D. Mcmeekin +2 more
2006Gynecologic Oncology48 citations
Semantic Scholar
Phase II evaluation of topotecan in carcinosarcoma of the uterus: a Gynecologic Oncology Group study.
D. Miller, J. Blessing, J. Schilder, A. Munkarah +1 more
2005Gynecologic Oncology48 citations
Semantic Scholar
A phase II evaluation of flavopiridol as second-line chemotherapy of endometrial carcinoma: a Gynecologic Oncology Group study.
E. Grendys, J. Blessing, R. Burger, J. Hoffman
2005Gynecologic Oncology47 citations
Semantic Scholar
Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.
P. Fracasso, J. Blessing, M. Morgan, A. Sood +1 more
2003Journal of Clinical Oncology45 citations
Semantic Scholar
Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group.
H. Smith, J. Blessing, L. Vaccarello
2002Gynecologic Oncology43 citations
Semantic Scholar
Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.
J. Edmonson, J. Blessing, J. Cosin, D. Miller +2 more
2002Gynecologic Oncology42 citations
Semantic Scholar
A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: a gynecologic oncology group study.
D. Tait, J. Blessing, J. Hoffman, K. Moore +4 more
2011Gynecologic Oncology38 citations
Semantic Scholar
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Agustin Garcia, J. Blessing, K. Darcy, H. Lenz +3 more
2007Gynecologic Oncology35 citations Open access
Semantic Scholar
A Phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group study)
J. Arseneau, J. Blessing, F. Stehman, R. Mcgehee
2004Investigational new drugs35 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Miller×8
Invite
D. Miller — researcher profile on SciRah
R. Mannel×8
Invite
R. Mannel — researcher profile on SciRah
P. Rose×7
Invite
P. Rose — researcher profile on SciRah
K. Degeest×5
Invite
K. Degeest — researcher profile on SciRah

×4

Invite

D. Moore — researcher profile on SciRah

Invite

P. Hanjani — researcher profile on SciRah

Invite

J. Hoffman — researcher profile on SciRah

Invite

M. Hensley — researcher profile on SciRah

Invite

S. Waggoner — researcher profile on SciRah

Invite

S. Lentz — researcher profile on SciRah

Invite

R. Mcgehee — researcher profile on SciRah

Invite

B. Monk — researcher profile on SciRah